| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/21/1996 | CN1129447A Tri-substituted imidazoles having multiple therapeutic properties |
| 08/21/1996 | CN1129216A Hydroxamic acid derivatives with tricylic substitution |
| 08/21/1996 | CN1129110A Preparation method for lameness-relieving injection |
| 08/20/1996 | US5547853 CD2-binding domain of lymphocyte function associated antigen 3 |
| 08/16/1996 | CA2169433A1 Adhesion receptor antagonists |
| 08/15/1996 | WO1996024572A1 Method for purifying diacetyl rhein |
| 08/15/1996 | WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 08/15/1996 | WO1996011685A3 Use of indole derivatives for the treatment of various diseases |
| 08/15/1996 | CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 08/14/1996 | EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration |
| 08/14/1996 | EP0726074A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 08/14/1996 | EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 08/13/1996 | US5545635 Inhibiting bone loss with equilenin |
| 08/08/1996 | WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors |
| 08/08/1996 | WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
| 08/08/1996 | WO1996023504A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates |
| 08/08/1996 | DE19503190A1 Mittel zur Beeinflussung von Störungen der Knochenbildung Means for influencing of disorders of bone formation |
| 08/08/1996 | CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors |
| 08/07/1996 | EP0724881A1 Method for treating smoking-related bone loss |
| 08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
| 08/07/1996 | EP0724561A1 Calcium receptor-active arylalkyl amines |
| 08/07/1996 | EP0724459A1 Formulations for delivery of osteogenic proteins |
| 08/07/1996 | CN1032470C Method for processing sulfur-containing heterocyclic compound |
| 08/01/1996 | WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness |
| 08/01/1996 | CA2168067A1 Method for treating smoking-related bone loss |
| 07/31/1996 | EP0723544A1 ALKOXY ALKYL CARBAMATES FROM IMIDAZO (1,2-a)PYRIDINES |
| 07/31/1996 | EP0723439A1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127135A Weibikang capsule |
| 07/24/1996 | CN1127131A Making method of oral capsule for curing difficult and complicated fracture |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/17/1996 | EP0609289B1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 07/17/1996 | CN1126601A Fracture setting medicine |
| 07/16/1996 | US5536812 Calcitonin analogue and use thereof |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536713 Osteoporosis |
| 07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/10/1996 | EP0720857A1 Syringe |
| 07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
| 07/09/1996 | US5534527 Treatment of osteoporosis |
| 07/09/1996 | US5533836 Compositions and methods for stimulating the growth of osteoblasts |
| 07/04/1996 | WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/03/1996 | EP0719782A1 Optically active benzothiepin derivative, its preparation and use |
| 07/03/1996 | EP0719775A1 Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/03/1996 | EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719148A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1125604A Comedo-elimination preparation |
| 07/03/1996 | CN1125575A Adhesion receptor antagonists |
| 07/02/1996 | US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents |
| 07/02/1996 | CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs |
| 06/29/1996 | CA2166165A1 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/29/1996 | CA2166152A1 Optically active benzothiepin derivative, its preparation and use |
| 06/27/1996 | WO1996019206A1 Therapeutic preparation for inhalation containing parathyroïd hormone, pth |
| 06/26/1996 | CN1125442A Imidazole lipoxygenase inhibitors |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5529991 Oral 1α-hydroxyprevitamin D |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018403A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 06/20/1996 | CA2207911A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss |
| 06/19/1996 | EP0505452B1 Use of inositolphosphates for preparing medicament |
| 06/19/1996 | CN1124654A External use medicine for traumatic injuries |
| 06/18/1996 | CA1338376E Regimen for treating osteoporosis |
| 06/15/1996 | CA2164916A1 Vitamin d compounds and method of preparing these compounds |
| 06/13/1996 | WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/13/1996 | WO1996017616A1 Kit for osteoporosis treatment cycle |
| 06/13/1996 | CA2207028A1 Kit for osteoporosis treatment cycle |
| 06/13/1996 | CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/12/1996 | CN1124151A "Guyankang" adhesive plaster for curing osteomyelitis |
| 06/11/1996 | US5525354 Salts of dichloromethylene bisphosphonic acid in drug delivery form with acid-dissolving enteric coating, for oral administration |
| 06/06/1996 | WO1996016646A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 06/06/1996 | CA2206422A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/04/1996 | US5523309 Benzofuran pharmaceutical compounds |
| 05/30/1996 | WO1996016036A1 18-nor-vitamin d compounds |
| 05/30/1996 | WO1996016035A1 18,19-dinor-vitamin d compounds |
| 05/30/1996 | CA2206876A1 18,19-dinor-vitamin d compounds |
| 05/30/1996 | CA2206873A1 18-nor-vitamin d compounds |
| 05/29/1996 | EP0713653A1 Fortified fruit juice |
| 05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/28/1996 | US5521315 Olefin substituted long chain compounds |
| 05/24/1996 | CA2163466A1 Fortified fruit juices |
| 05/23/1996 | WO1996014857A1 Multicatalytic protease inhibitors |
| 05/23/1996 | CA2202760A1 Multicatalytic protease inhibitors |
| 05/22/1996 | EP0712303A1 Skin patches and methods for providing testosterone |
| 05/22/1996 | EP0502081B1 Proliferative action of leukaemia inhibitory factor on satellite cells |
| 05/17/1996 | WO1996014081A1 Use of erythropoietin in the treatment of rheumatoid arthritis |